Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Am J Psychiatry. 2012 Oct;169(10):1065–1072. doi: 10.1176/appi.ajp.2012.11091325

TABLE 2.

Unadjusted and Adjusted Odds Ratios for Treatment Resistance by Medication Class in the i2b2 Treatment-Resistant Cohorta

Treatment-Resistant Depression
Medication Class Unadjusted
Model 1b
Model 2c
Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI
Nonsteroidal anti-inflammatory drugs (NSAIDs)
 and COX-2 inhibitors and salicylatesd
1.55 1.21–2.00 1.42 1.09–1.85 1.17 0.83–1.64
NSAIDs only 1.74 1.40–2.18 1.56 1.23–1.97 1.31 1.03–1.76
COX-2 inhibitors only 0.83 0.61–1.12 0.89 0.65–1.22 0.78 0.54–1.12
Salicylates only 1.01 0.82–1.25 1.15 0.91–1.47 1.17 0.86–1.59
a

The reference group for these analyses is treatment responsive. Likelihood-ratio test compared the fit for model 2 > model 1 > unadjusted (p<0.001 for all comparisons).

b

The model 1 analysis included age, sex, race, and payer.

c

The model 2 analysis included model 1 variables as well as log-transformed fact count, age-adjusted Charlson comorbidity index, history of hypertension, history of hyperlipidemia, history of myocardial infarction, history of stroke, and history of type 2 diabetes.

d

Analysis is consistent with that of Warner-Schmidt et al. (3).